Back to Search
LINDSAY ADAM, M.D.
M.D.
Ophthalmology Physician
NPI: 1427360783IndividualAccepts Medicare
Specialties, Licenses & Credentials
Ophthalmology PhysicianPrimary
Ophthalmology
Code: 207W00000X
201400827(NC)
CMS Specialties
PrimaryOPHTHALMOLOGY
Education
WRIGHT STATE UNIVERSITY BOONSHOFT SCHOOL OF MEDICINE
Class of 2010
Research & Publications (20)
miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy.
PMID 19671845·Clin Cancer Res·2009
4-observational
Role for limited neck exploration in young adults with apparently sporadic primary hyperparathyroidism.
PMID 18335277·World J Surg·2008
8-other
Adenoviral mediated interferon-alpha 2b gene therapy suppresses the pro-angiogenic effect of vascular endothelial growth factor in superficial bladder cancer.
PMID 17437845·J Urol·2007
7-preclinical
Exploring Renner-Teller induced quenching in the reaction H(2S)+NH(a 1Delta): a combined experimental and theoretical study.
PMID 17249868·J Chem Phys·2007
8-other
Experimental and theoretical investigation of the reaction NH(X3Sigma-) + H(2S)-->N(4S) + H2(X1)Sigmag +).
PMID 15836209·J Chem Phys·2005
8-other
Clinical applications for targeted therapy in bladder cancer.
PMID 15862621·Urol Clin North Am·2005
6-review
Tiam1 overexpression potentiates heregulin-induced lymphoid enhancer factor-1/beta -catenin nuclear signaling in breast cancer cells by modulating the intercellular stability.
PMID 11328805·J Biol Chem·2001
8-other
A three-dimensional and temporo-spatial model to study invasiveness of cancer cells by heregulin and prostaglandin E2.
PMID 11196203·Cancer Res·2001
8-other
Interferon-alpha signaling promotes nucleus-to-cytoplasmic redistribution of p95Vav, and formation of a multisubunit complex involving Vav, Ku80, and Tyk2.
PMID 10673353·Biochem Biophys Res Commun·2000
8-other
Regulation of microfilament reorganization and invasiveness of breast cancer cells by kinase dead p21-activated kinase-1.
PMID 10766836·J Biol Chem·2000
8-other
ADAM10 as a therapeutic target for cancer and inflammation.
PMID 19601831·Curr Pharm Des·2009
6-review
Relaxation of NH(a(1)Delta, v = 1) in collisions with H((2)S): an experimental and theoretical study.
PMID 19569615·J Phys Chem A·2009
8-other
Sensitivity to epidermal growth factor receptor inhibitor requires E-cadherin expression in urothelial carcinoma cells.
PMID 18316572·Clin Cancer Res·2008
7-preclinical
Erosion of the Nuss bar into the internal mammary artery 4 months after minimally invasive repair of pectus excavatum.
PMID 18280298·J Pediatr Surg·2008
5-case
The Nuclear Factor Y subunits NF-YB2 and NF-YB3 play additive roles in the promotion of flowering by inductive long-day photoperiods in Arabidopsis.
PMID 18600346·Planta·2008
8-other
2-Arylbenzoxazoles as novel cholesteryl ester transfer protein inhibitors: optimization via array synthesis.
PMID 18374566·Bioorg Med Chem Lett·2008
8-other
Therapeutic IMC-C225 antibody inhibits breast cancer cell invasiveness via Vav2-dependent activation of RhoA GTPase.
PMID 18829495·Clin Cancer Res·2008
8-other
Is vascular endothelial growth factor modulation a predictor of the therapeutic efficacy of gefitinib for bladder cancer?
PMID 18639280·J Urol·2008
7-preclinical
Rove beetles (Coleoptera: Staphylinidae) collected during the long term ecological research in a Hungarian oak forest.
PMID 18831387·J Environ Biol·2008
7-preclinical
Thyroid hormone receptor alpha1 follows a cooperative CRM1/calreticulin-mediated nuclear export pathway.
PMID 18641393·J Biol Chem·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2709 BLUE RIDGE ROAD, SUITE 100
RALEIGH, NC 27607 - Phone
- (919) 782-5400
Quick Facts
- NPI
- 1427360783
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 16
- Publications
- 20
Are you this provider?
Claim Your Profile